The ANALYSIS OF THE RISKS OF CANNABIS USE FOR GLAUCOMA TREATMENT: LITERATURE REVIEW
DOI:
https://doi.org/10.36557/2674-8169.2026v8n3p990-999Keywords:
Glaucoma, CannabisAbstract
Objective: To analyze the risks associated with the use of cannabis during glaucoma treatment and its effects. Methods: A search was conducted in the National Library of Medicine (PubMed) and the Virtual Health Library (VHL) to compile the bibliographic compilation of this literature review. The descriptors used were "cannabis", "glaucoma" and "treatment". Articles published in the last 5 years (2019-2024), full texts and written in English were included. Duplicate articles or articles that were not related to the objective of the study were excluded. Results: Of the 25 selected studies, 2 were clinical trials, 2 controlled clinical trials or 21 were observational studies. Among the studies selected with the application of the inclusion criteria, 9 concluded that the use of cannabis for the treatment of glaucoma was beneficial, 3 concluded that the use was associated with long-term harm, and 2 considered it not recommended as an isolated treatment. 3 studies also indicated a relationship between the use of medical cannabis associated with a reduction in eye pressure in glaucoma, in addition to 4 demonstrating its use as promising for treatment, 1 demonstrated no significant clinical improvement and another reported that its use is limited and indicated only for some specific groups. In addition, 2 studies further state that we should further increase research on the therapeutic properties of cannabis. Final considerations: In this way, it has been observed that the use of cannabis in the treatment of glaucoma shows promise in reducing intraocular pressure, especially with THC. Different forms of consumption, such as oils and edibles, offer alternatives to smoking, minimizing risks. However, long-term studies are needed to evaluate efficacy and possible side effects. A personalized approach and more research are essential to ensure the safe and effective use of cannabis in the treatment of glaucoma.
Downloads
References
Journal of AOAC INTERNATIONAL. 2019 Mar 1;102(2):412–20..
Klumpers LE, Thacker DL. A Brief Background on Cannabis: From Plant to Medical Indications.
3. Sameh Mosaed, Smith AK, John, Minckler DS, Fitzgerald RL, Grelotti D, et al. The Relationship
Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects.
Frontiers in medicine. 2022 Jan 17;8.
Wang MTM, Danesh-Meyer HV. Cannabinoids and the eye. Survey of Ophthalmology [Internet].
;66(2):327–45. Available from: HTTPS://PUBMED.NCBI.NLM.NIH.GOV/32763339/
Lehrer S, Rheinstein PH. Cannabis, Intraocular Pressure, and the Growth Arrest-Specific 7
(GAS7) Gene: A Retrospective Analysis. Cureus. 2022 Apr 7
Jugl S, Okpeku A, Costales B, Morris EJ, Alipour-Haris G, Hincapie-Castillo JM, et al. A Mapping
Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved
Conditions in the USA from 2016 to 2019. Medical Cannabis and Cannabinoids. 2021 Feb
;4(1):21–42
7. Jerushalmi S, Maymon M, Dombrovsky A, Regev R, Schmilovitch Z, Namdar D, et al. Effects of
steam sterilization on reduction of fungal colony forming units, cannabinoids and terpene levels in
medical cannabis inflorescences. Scientific Reports. 2021 Jul 7;11(1).
Stasiłowicz A, Tomala A, Podolak I, Cielecka-Piontek J. Cannabis sativa L. as a Natural Drug
Meeting the Criteria of a Multitarget Approach to Treatment. International Journal of Molecular
Sciences. 2021 Jan 14;22(2):778.
Khamenka N, Pikirenia U. Knowledge, attitudes and beliefs about medical cannabis among the
medical students of the Belarus State Medical University. Complementary Therapies in Medicine.
Mar;57:102670.
Proulx V, Tousignant B. Drugs of abuse and ocular effects. Clinical and Experimental Optometry.
Mar 15;1–12.
Rafuse P, Buys YM. Medical use of cannabis for glaucoma. Can J Ophthalmol. 2019
Feb;54(1):7-8. doi: 10.1016/j.jcjo.2018.11.001. PMID: 30851777.
Weldy EW, Stanley J, Koduri VA, McCourt EA, Patnaik JL, Kahook MY, et al. Perceptions of
Marijuana Use for Glaucoma from Patients, Cannabis Retailers, and Glaucoma Specialists.
Ophthalmology Glaucoma. 2020 Nov;3(6):453–9.
Yakobashvili D, Shah R, Oydanich M, Khouri AS. Public Perception of Marijuana Use for the
Treatment of Glaucoma. Journal of Glaucoma. 2023 Mar 3;Publish Ahead of Print.
Jia J (Sasha), Mehran N, Purgert R, Zhang Q (Ed), Lee D, Myers JS, et al. Marijuana and
Glaucoma: A Social Media Content Analysis. Ophthalmology Glaucoma. 2021
Jul;4(4):400–4.
Vallée A, Lecarpentier Y, Vallée JN. Cannabidiol and the Canonical WNT/β-Catenin Pathway in
Glaucoma. International Journal of Molecular Sciences. 2021 Apr 6;22(7):3798.
Lopez MJ, Nataneli N. Cannabis Use for Glaucoma and Associated Pain [Internet]. PubMed.
Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jun 25]. Available from: HTTPS://
PUBMED.NCBI.NLM.NIH.GOV/34283478/
Passani A, Posarelli C, Sframeli AT, Perciballi L, Pellegrini M, Guidi G, et al. Cannabinoids in
Glaucoma Patients: The Never-Ending Story. Journal of Clinical Medicine [Internet]. 2020 Dec
;9(12). Available from: HTTPS://PUBMED.NCBI.NLM.NIH.GOV/33302608/
Unal E, Anderson B, Helber A, Marks JH. Cannabinoids : A Guide for Use in the World of
Gastrointestinal Disease. Journal of Clinical Gastroenterology [Internet]. 2020 Oct 3 [cited 2023
Nov 12];54(9):769–88. Available from: https://www.ingentaconnect.com/content/wk/jcga/
/00000054/00000009/art00006
Medicamentos para distúrbios oculares comuns. Medicamentos Médicos Para Lá. 2 de dezembro
de 2019;61(1586):187-194. PMID: 31770361.
Abyadeh M, Gupta V, Paulo JA, Gupta V, Chitranshi N, Godinez A, et al. A Proteomic View of
Cellular and Molecular Effects of Cannabis. Biomolecules. 2021 Sep 27;11(10):1411
Attitudes and Perceptions Toward the Use of Medical Marijuana by Glaucoma
Specialists.Bergman, Zachary; Douglas, John; Wang, Jiangxia; Idowu, Omolola; Kaleem, Mona. J
Glaucoma ; 31(2): 67-71, 2022 Feb 01.
Montero-Oleas N, Arevalo-Rodriguez I, Nuñez-González S, Viteri-García A, Simancas-
Racines D. Therapeutic use of cannabis and cannabinoids: an evidence mapping and
appraisal of systematic reviews. BMC Complementary Medicine and Therapies. 2020 Jan
;20(1).
Pujari R, Jampel HD. Treating Glaucoma with Medical Marijuana: Peering through the Smoke.
Ophthalmology Glaucoma. 2019 Jul;2(4):201–3.
Daga FB, Almeida I, Prata TS, Paranhos Júnior A. Marijuana for glaucoma treatment: a recipe for
disaster. Arquivos Brasileiros de Oftalmologia. 2021;84(2).
Khalid S, Almalki FA, Ben Hadda T, Bader A, Abu-Izneid T, Berredjem M, et al. Medicinal
Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against
COVID-19? Current Pharmaceutical Design. 2020 Dec 2;26.
1.Lee BH, Sideris A, Ladha KS, Johnson RL, Wu CL. Cannabis and Cannabinoids in the
Perioperative Period. Anesthesia & Analgesia. 2022 May 13;Publish Ahead of Print.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pedro Henrique de Alvarez Pereira, Davi Miguel dos Santos Sá
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.
